2 quarters left ? They have a 5 million dollar tax rebate coming in later this year plus non dilutive funding coming in for phase 2 so don’t think they need any money until most likely phase 3 and at a significantly higher valuation. The more important thing is the next 2 months they clear remaining cohorts and AGN prove up NYR mechanism of action of inhibiting calcium to protect the brain. AGN runs towards a 400-500 million market cap NYR will follow suit.
AGN comes out with any efficacy running to a 400-500 million market cap and that’s where NYR will be. 400 million market cap is $2.50 a stock. Our time will come and AGN puts NYR success in the bag so for me I just hold and buy more.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)